ATC代碼 (D01)

ATC代碼D01(皮膚病用抗真菌藥)是解剖學治療學及化學分類系統的一個藥物分組,這是由世界衛生組織藥物統計方法整合中心(The WHO Collaborating Centre for Drug Statistics Methodology)所制定的藥品及其它醫用產品的官方分類系統。分組D01是D皮膚病的一部分。[1]

ATC代碼
D 皮膚科用藥
D01 皮膚病用抗真菌藥

Antifungals for dermatological use)

D02 潤膚劑及保護劑

(Emollients and protectives)

D03 治療創傷潰瘍製劑

(Preparations for treatment of wounds and ulcers

D04 止癢藥(包括抗組胺藥麻醉劑等)

Antipruritics, including antihistamines, anesthetics, etc.)

D05 抗銀屑病藥

Antipsoriatics

D06 皮膚病用抗生素化學治療藥

(Antibiotics and chemotherapeutics for dermatological use)

D07 皮質類固醇皮膚科製劑

(Corticosteroids, dermatological preparations)

D08 消毒劑殺菌劑

Antiseptics and disinfectants)

D09 醫用敷料

Medicated dressings

D10粉刺製劑

(Anti-acne preparations)

D11 其它皮膚科製劑

(Other dermatological preparations)

ATCvet專用
QD51 治療製劑

(Products for the treatment of claws and hoofs)


A·B·C·D·G·H·QI·J·L·M·N·P·R·S·V

獸用代碼(ATCvet碼)可以在人用ATC代碼前加Q字母:QD01[2]。沒有相應人用ATC代碼的ATCvet在以下列表中通過前置Q字母表示。

國家ATC分類可能包括列表中沒有的其它分類,列表為世界衛生組織(WHO)版本。

D01A 局部用抗真菌藥(Antifungals for topical use)

D01AA 抗生素類(Antibiotics)

D01AA01 制黴素(Nystatin)
D01AA02 那他黴素(Natamycin)
D01AA03 曲古黴素(Hachimycin)
D01AA04 培西洛星(Pecilocin)
D01AA06 美帕曲星(Mepartricin)
D01AA07 吡咯尼群(Pyrrolnitrin)
D01AA08 灰黃黴素(Griseofulvin)
D01AA20 複方(Combinations)

D01AC 咪唑三唑衍生物(Imidazole and triazole derivatives)

D01AC01 克霉唑(Clotrimazole)
D01AC02 咪康唑(Miconazole)
D01AC03 益康唑(Econazole)
D01AC04 氯咪達唑(Clomidazole)
D01AC05 異康唑(Isoconazole)
D01AC06 噻苯達唑(Tiabendazole)
D01AC07 噻康唑(Tioconazole)
D01AC08 酮康唑(Ketoconazole)
D01AC09 硫康唑(Sulconazole)
D01AC10 聯苯苄唑(Bifonazole)
D01AC11 奧昔康唑(Oxiconazole)
D01AC12 芬替康唑(Fenticonazole)
D01AC13 奧莫康唑(Omoconazole)
D01AC14 舍他康唑(Sertaconazole)
D01AC15 氟康唑(Fluconazole)
D01AC16 氟曲馬唑(Flutrimazole)
D01AC20 複方(Combinations)
D01AC52 咪康唑複方(Miconazole, combinations)
D01AC60 聯苯苄唑複方(Bifonazole, combinations)
QD01AC90 恩康唑(Enilconazole)

D01AE 局部用其它抗真菌藥(Other antifungals for topical use)

D01AE01 溴氯水楊酸苯胺(Bromochlorosalicylanilide)
D01AE02 甲品紅(Methylrosaniline)
D01AE03 三溴間甲酚(Tribromometacresol)
D01AE04 十一烯酸(Undecylenic acid)
D01AE05 聚諾昔林(Polynoxylin)
D01AE06 2-(4-氯苯氧基)乙醇(2-(4-chlorphenoxy)-ethanol)
D01AE07 氯苯甘醚(Chlorphenesin)
D01AE08 替克拉酮(Ticlatone)
D01AE09 舒苯汀(Sulbentine)
D01AE10 羥苯乙酯(Ethyl hydroxybenzoate)
D01AE11 鹵普羅近(Haloprogin)
D01AE12 水楊酸(Salicylic acid)
D01AE13 二硫化硒(Selenium sulfide)
D01AE14 環吡酮(Ciclopirox)
D01AE15 特比萘芬(Terbinafine)
D01AE16 阿莫羅芬(Amorolfine)
D01AE17 地馬唑(Dimazole)
D01AE18 托萘酯(Tolnaftate)
D01AE19 托西拉酯(Tolciclate)
D01AE20 複方(Combinations)
D01AE21 氟胞嘧啶(Flucytosine)
D01AE22 萘替芬(Naftifine)
D01AE23 布替萘芬(Butenafine)
D01AE54 十一烯酸,複方(Undecylenic acid, combinations)
QD01AE91 布羅波爾(Bronopol)
QD01AE92 苄硫嗪酸(Bensuldazic acid)

D01B 系統用抗真菌藥(Antifungals for systemic use)

D01BA 系統用抗真菌藥(Antifungals for systemic use)

D01BA01 灰黃黴素(Griseofulvin)
D01BA02 特比萘芬(Terbinafine)


參考文獻

  1. ^ ATC Index. WHO Collaborating Centre for Drug Statistics Methodology. 
  2. ^ ATCvet Index. WHO Collaborating Centre for Drug Statistics Methodology.